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Abstract Stathmin is a ubiquitous cytoplasmic protein whose
phosphorylation state changes markedly in response to extra-
cellular signals, and during the cell cycle. To clarify the function
of stathmin, its four phosphorylation sites were mutated to either
alanines (4A-stathmin) or glutamates (4E-stathmin). In trans-
fected cells, 4A-stathmin caused a strong G2/M block and also
inhibited the responsiveness of a co-transfected fos promoter/
luciferase reporter plasmid to serum stimulation, whereas wild
type and 4E-stathmin had relatively minor effects. These results
support the idea that stathmin plays a role in multiple cellular
processes and indicate that the regulation of the phosphorylation
state of stathmin is likely to determine its action.
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1. Introduction
An intricate network of proteins controls the multitude of
processes required for proper cellular function and behavior.
The activity of these proteins is often regulated by post-trans-
lational modi¢cations, particularly by phosphorylation. The
ubiquitous 19 kDa cytoplasmic phosphoprotein stathmin [1],
also designated p19 [2], Op18 [3], and prosolin [4], has been
proposed to play an important role in regulating cellular proc-
esses [5]. The rapid phosphorylation of stathmin in response
to a wide range of extracellular e¡ectors [6] and the diversity
of phosphoforms observed has prompted the hypothesis that
it may act as a relay integrating various intracellular signaling
pathways [5]. Stathmin expression is highly regulated during
development, and is most abundant in the adult brain [7^9].
Interestingly, its expression is increased in a number of neo-
plastic cells [3,10,11].
Stathmin consists of a C-terminal, mainly K-helical domain
which may participate in coiled-coil interactions [12] and of an
N-terminal domain with four serine phosphorylation sites, at
positions 16, 25, 38 and 63 [6]. The sites at serines 25 and 38
have consensus sequences for proline directed kinases, and it
has been shown that serine 25 is a target for MAP kinase
[6,13^15], whereas serine 38 is a target for phosphorylation
by cdks [6], although there is some overlap in the speci¢city at
these sites. Serines 16 and 63 can be phosphorylated by pro-
tein kinase A [6,16], and serine 16 has been shown to be a
target for both the Ca2/calmodulin dependent kinase-Gr [17],
and CaM kinase II (S. le Gouvello, V. Manceau and A. Sobel,
unpublished).
Stathmin phosphorylation has also been shown to vary
during the cell cycle with a major increase at all four sites
occurring during mitosis [11,18,19]. Anti-sense inhibition of
stathmin expression inhibits cell growth and causes a block
in the G2/M phase of the cell cycle [11,20]. Overexpression of
mutant forms of stathmin with any of the four serines
changed to alanines causes a G2/M block in K562 cells
[19,20]. The cause of this phenotype is likely to be related to
the observation that stathmin is important in the regulation of
microtubule dynamics [21^25].
In this study, we have overexpressed both wild type and
mutant forms of stathmin in the human embryonic kidney
293 cell line and examined the e¡ects on cell growth and
signal transduction. We have extended previous studies by
comparing the activities of a mutant in which each of the
four phosphorylation sites was mutated to an alanine, with
a mutant containing a glutamic acid at each site designed to
mimic hyper-phosphorylated stathmin. Overexpression of the
alanine mutant has a strong e¡ect on both cell division and
the response to serum-induced signal transduction, whereas
the e¡ect of the glutamic acid mutant is much weaker, thus
indicating the importance of the multiple phosphorylation of
stathmin in diverse cellular processes.
2. Materials and methods
2.1. Plasmid construction
DNA manipulations were carried out using standard techniques
[26]. Stathmin mutants in which four serine phosphorylation sites
were mutated to either alanine (4A-stathmin) or glutamic acid resi-
dues (4E-stathmin) were constructed by the ‘megaprimer’ PCR tech-
nique [27] with oligonucleotide primers from Genset (France), and the
human stathmin cDNA [28] as a substrate.
To express a C-terminal myc epitope-tagged form of stathmin in
mammalian cells, pcDNA3stath/myc was constructed with primers
encoding the myc tag [29] cloned into BamHI/HindIII cut pcDNA3
(Invitrogen), and the stathmin coding sequence was introduced with
PCR generated 5P-KpnI and 3P-BamHI restriction sites. The 4A- and
4E-stathmin/myc expression vectors were constructed similarly. Ex-
pression vectors for the truncated forms were generated with primers
amplifying either the N-terminal 65 amino acids (vC-stathmin) or the
C-terminal 85 amino acids (vN-stathmin), with the same restriction
sites used for the full length forms.
For stable episomal expression, the stathmin/myc unit constructed
above was subcloned into the episomal mammalian expression vector
pCEP4 (Invitrogen) as a HindIII/XhoI fragment. pCEPLgal was con-
structed as a control to express L-galactosidase in this system. The L-
galactosidase cDNA was excised from pUHG 16-3 (a gift from H.
Bujard) using XbaI sites, and subcloned into pCEP4.
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2.2. Cell culture, transfections and fos promoter assays
Cells of the human embryonic kidney 293 cell line transfected with
the EBNA-1 gene (293-EBNA) (Invitrogen) were cultured in DMEM
containing 10% fetal calf serum and 200 Wg/ml G418 (Gibco BRL) at
37‡C in 5% CO2. 293 cells were transfected with Lipofectamine (Gib-
co BRL) according to the manufacturer’s recommendations, with 2 Wg
of a pCEP4 derived stathmin expression vector. 24 h post transfec-
tion, medium containing 400 Wg/ml hygromycin (Sigma) was added.
The medium was changed every 2 days for a week and then cells were
passaged by vigorous pipetting to a 10 cm plate. After 2 more days
selection the cells were washed with DMEM and viable cells were
counted by trypan blue exclusion prior to further experiments.
For the fos promoter assays, transfections were performed using 1
Wg stathmin expression vector and 0.5 Wg each of a fos luciferase
reporter vector [30] (a gift from Dr. A.D. Sharrocks, Newcastle-
Upon-Tyne, UK) and pRSVL-gal (Pharmacia). 6 h after the start of
transfection the medium was removed and the cells washed twice in
DMEM. Fresh medium containing 0.5% fetal calf serum was then
added. After a further 36 h incubation, stimulation was carried out
by the addition of DMEM containing 20% fetal calf serum. 8 h later
the cells were harvested into 200 Wl of Reporter Lysis Bu¡er (Prom-
ega), and the levels of luciferase (Promega assay system) and L-gal-
actosidase [26] were measured. The ¢nal activity reading was obtained
by dividing each luciferase reading by the corresponding L-galactosi-
dase reading.
2.3. SDS-PAGE and Western blotting
SDS-PAGE on 13% polyacrylamide gels and immunoblotting were
performed as described [31]. The primary antibody was added at a
suitable dilution in blocking bu¡er with 1% dry milk, and the blot was
probed with an appropriate HRP conjugated secondary antibody
(Dako) before development using ECL (Amersham).
2.4. Microscopic analysis and £ow cytometry
Immuno£uorescence microscopy was performed using an Olympus
Provis £uorescence microscope. Cells grown on glass coverslips were
¢xed for 6 min with methanol at 320‡C. After washes with PBS and
blocking in PBS containing 3% BSA, cells were incubated overnight
with the primary antibody (either anti-myc monoclonal 9E10 (Onco-
gene Science) or anti K-tubulin monoclonal N356 (Amersham). After
washes with PBS containing 0.1% Tween 20, rhodamine conjugated
anti-mouse secondary antibodies (BioSys) were used to visualize the
antibody staining pattern, and Hoechst 33258 stain (Molecular
Probes) at 5 Wg/ml for cell nuclei.
Cells selected in hygromycin were analyzed for DNA content after
overnight ¢xation in 70% ethanol and incubation in propidium iodide.
Flow cytometry was carried out using a Becton Dickinson FACScan
counting at least 10 000 cells per sample. The data were collected using
the CELLQuest program (Becton and Dickinson). Cell cycle data was
analyzed using the program ModFit LT version 1.0 (Verity Software,
US).
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Fig. 1. Construction of mutant stathmin forms and expression in 293 cells. A: Schematic representation of the forms of stathmin expressed in
293 cells with a C-terminal myc epitope tag. The changes introduced into the wild type stathmin (WT) to make each mutant are: replacement
of all four phosphorylation sites with alanine (4A) or with glutamic acid (4E), and truncation of either the N-terminal (vN) or C-terminal (vC)
moieties of the molecule. B: 293 cells transfected transiently with expression plasmids for stathmin or its mutant forms were grown for 10 days
in hygromycin containing selection medium to enrich the population in transfected cells. Equal amounts of protein were separated by SDS-
PAGE and a Western blot was then probed with a polyclonal antiserum directed against the N-terminus of stathmin [9] or an anti-myc mono-
clonal antibody. The vC-stathmin band appears very faint, probably due to degradation of the corresponding protein. Limited degradation is
probably also the cause of the presence of some low molecular weight bands revealed by the anti-myc antibody in the 4A and 4E mutant ex-
pressing cells. vN-stathmin is revealed only by the anti-myc antibody, as it lacks the N-terminal region recognized by the anti-stathmin antise-
rum.
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3. Results
3.1. The e¡ects of di¡erent stathmin forms on cell growth
in 293 cells
We investigated the importance of the regulation of stath-
min phosphorylation on cell growth by overexpression of var-
ious mutants. Constructs were made in which the phospho-
rylation sites were mutated to either alanine (4A-stathmin) or
glutamic acid residues (4E-stathmin). Two truncated forms of
stathmin were also generated: vC-stathmin consisting of the
N-terminal domain (amino acids 1^65) encompassing the four
phosphorylation sites, and vN-stathmin consisting of the C-
terminus (amino acids 65^149) encompassing most of the K-
helical domain and lacking the phosphorylation sites (Fig.
1A).
We had di⁄culty obtaining stable clones overexpressing the
di¡erent stathmin forms to a high level (S. Lawler, O. Gavet
and A. Sobel, unpublished). However, following transfection
of 293 cells with an episomal expression vector and 10 days
selection in hygromycin, it was possible to obtain populations
of strongly expressing cells. A L-galactosidase expression vec-
tor (pCEPLgal) transfected in parallel showed that virtually
all the cells in the culture were expressing recombinant protein
after the selection period. Western blotting demonstrated that
each form was expressed at a similar high level, with the
exception of vC-stathmin which was expressed poorly, prob-
ably due to degradation (Fig. 1B).
After the 10 day selection period, £ow cytometric analysis
of DNA content showed a strong accumulation of 4A-stath-
min expressing cells in G2/M, reaching 50% of the total pop-
ulation (Fig. 2). Moreover, a population of cells with a DNA
content of 8N was also seen and probably represents cells
undergoing endoreduplication (see below). Study of the
growth of these populations showed that the 4A-stathmin ex-
pressing cells grew extremely slowly in correlation with the
block in the cell cycle (Fig. 3). The expression of wild type
or 4E-stathmin caused a moderate increase in the percentage
of cells in G2/M compared with cells transfected with vector
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Fig. 2. Flow cytometry cell cycle analysis of selected 293 cell populations expressing stathmin or its mutant forms. After 10 days selection in
hygromycin containing medium of 293 cells transfected with expression vectors for stathmin or its mutant forms (see Fig. 1), cells were seeded
at 4U105 cells per 35 mm well. 48 h later they were harvested and the cell cycle pro¢le was analyzed by £ow cytometry after DNA staining
with propidium iodide. The graphic data (A) represent the results of a series of typical experiments. The table (B) summarizes the mean values
obtained from three experiments with each stathmin form, after calculation of the proportion of cells in the G0/G1, S and G2/M phases of the
cell cycle (see Section 2).
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alone and these cells also grew more slowly compared with the
control.
Phase-contrast microscopy showed that in addition to the
decreased number of cells obtained after transfection, a num-
ber of the cells in the culture were larger than the rest of the
population. The proportion of large cells was related to the
growth rate of the cells, with up to 25% of the cells expressing
4A-stathmin exhibiting this increase in size. Furthermore,
many of the normal sized cells which were present in this
culture had a spherical appearance and were easily detached
from the culture dish, possibly indicating a block in mitosis.
In cultures expressing wild type or 4E-stathmin a smaller
number of enlarged cells were observed, but overall the cells
in the culture appeared normal.
Immuno£uorescence microscopy was then carried out to
investigate further the phenotype of 4A-stathmin expressing
cells (Fig. 4). Hoechst staining showed that the nuclei of the
large cells were greatly enlarged and sometimes multilobal.
BrdU staining showed that DNA synthesis was taking place
in many of these cells (data not shown), indicating that they
might result from endoreduplication in agreement with the
presence of cells with a DNA content higher than 4N.
3.2. The e¡ect of di¡erent stathmin forms on the responsiveness
of a fos promoter/luciferase reporter
In addition to its role in the cell cycle, stathmin may be
important in signal transduction processes as seen by its rapid
phosphorylation in response to diverse extracellular stimuli
[5]. Therefore we tested our mutants in an assay for e⁄cacy
of signaling. The fos promoter is known to be a¡ected by
many stimuli, and was used to examine the e¡ects of stathmin
on serum stimulation by measuring the activity of a co-trans-
fected fos promoter/luciferase reporter plasmid, pfosfosTKluc
[30].
pcDNA3stath/myc or its derivatives were transiently co-
transfected into 293 cells with pfosfosTKluc and pRSVL-gal.
In normally growing cells, the expression of wild type stath-
min caused a small but reproducible increase in co-transfected
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Fig. 4. Morphology of 4A-stathmin expressing cells. Cells transfected with the WT or 4A-stathmin expression vector (see Fig. 1) were examined
by immuno£uorescence microscopy with anti-tubulin and by Hoechst DNA staining. A signi¢cant proportion of the 4A-stathmin expressing
cells displayed a striking morphology with large cells containing multilobal nuclei, as compared with the WT-stathmin expressing cells which
displayed a normal phenotype. Bar = 15 Wm.
Fig. 3. Growth of selected 293 cells expressing stathmin or its mu-
tant forms. After 10 days selection in hygromycin containing me-
dium of 293 cells transfected with expression vectors for stathmin
or its mutant forms (see Fig. 1), 3U104 cells per 35 mm well were
seeded and allowed to grow for 14 days in hygromycin. Growth
curves comparing the rates of growth of the various hygromycin re-
sistant populations are presented. Cell numbers were counted each
3 days in triplicate.
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fos promoter activity, as revealed by luciferase levels, which
reached a level approximately 1.5-fold more than in cells
transfected with vector alone (Fig. 5A). 4A-stathmin had a
stronger e¡ect, the increase over vector being up to 2-fold
whereas 4E-stathmin had a similar or slightly weaker e¡ect
than the wild type. vN-stathmin had no signi¢cant e¡ect on
the level of fos activity.
In cells grown in low serum for 36 h after transfection, fos
promoter activity was determined in response to stimulation
with serum. This revealed an inhibition of fos promoter stim-
ulation in cells transfected with wild type or 4A-stathmin, the
level reaching 40% of that observed using the vector alone or
vN-stathmin (Fig. 5B). 4E-stathmin had a much weaker e¡ect
on fos promoter activity than the other full length forms.
Western blot analysis showed that the observed e¡ects were
not due to di¡erences in expression levels, which were equiv-
alent (data not shown).
These results show that stathmin has complex e¡ects on the
fos promoter, causing a small stimulation in normally growing
cells but preventing subsequent stimulation in response to
growth inducing signals. Although these e¡ects are not very
large, they were extremely reproducible, and compare well
with e¡ects seen in similar kinds of studies using luciferase
reporter systems.
4. Discussion
Our studies show that stathmin plays a role in both the cell
cycle and signal transduction processes. A number of mutants
were expressed each of which had a distinct e¡ect. Overex-
pression of wild type stathmin in 293 cells signi¢cantly af-
fected intracellular signaling as revealed by a fos promoter
directed reporter gene, whereas it only moderately a¡ected
cell growth. In contrast, the non-phosphorylatable 4A-stath-
min strongly inhibited both serum responsiveness and growth,
blocking the cells in G2/M. The 4E mutant, designed to mimic
the fully phosphorylated form of stathmin seen in mitosis,
only moderately perturbed both cell signaling and the cell
cycle, and the truncated form corresponding to the C-terminal
‘interaction’ domain [12] of stathmin had no signi¢cant e¡ect.
Altogether, our results underline the involvement of stathmin
and the importance of the regulation of its phosphorylation in
di¡erent cellular processes.
The G2/M block induced by overexpression of 4A-stathmin
in 293 cells is in agreement with similar observations in K562
cells [20]. We have extended these studies by using the 4E
mutant whose e¡ects appear indistinguishable from the wild
type. This result suggests that the phosphorylated form of
stathmin may be permissive for the G2/M transition, and
that the unphosphorylated form of stathmin may contribute
to a kind of ‘checkpoint’ e¡ect, overrun only after extensive
phosphorylation of stathmin by several activated kinases.
Stathmin is known to be highly expressed in some non-
proliferating cells, for example in the nervous system
[7,16,32], and has other roles related to the relay and integra-
tion of intracellular signaling pathways controlling diverse
physiological processes not necessarily related to cell prolifer-
ation [5,33]. We therefore tested the mutants in a signal trans-
duction assay, by measuring their e¡ect on the serum respon-
siveness of a co-transfected fos promoter. The e¡ects on the
fos promoter appear distinct from those on the cell cycle as
seen with the 4E mutant which behaves similarly to the wild
type in the cell cycle assays, but has much less e¡ect in the
signaling assay. Stathmin appears to have a complex e¡ect on
this process as the 4A- and wild type stathmin block signaling,
but cause a stimulation of the fos promoter in normally grow-
ing cells possibly due to a stress-like e¡ect of stathmin over-
expression.
The recently proposed role of stathmin as a potential reg-
ulator of microtubule dynamics [21^25] can explain the e¡ects
we observed in this study, as it has been shown also that
treating cells with agents that disrupt microtubule function
can activate the SRE of the fos promoter [34], and that im-
paired spindle function in Xenopus can activate MAP kinase
which is known to activate fos expression [35]. Microtubule
rearrangements also play key roles during the cycle [36].
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Fig. 5. E¡ects of overexpression of stathmin and its mutant forms
on cotransfected fos-promoter activity. Expression plasmids for
stathmin or its mutant forms (see Fig. 1) were co-transfected with
pTKfosfosluc and pRSVLgal. After transfection, the cells were
maintained in normal culture medium for 24 h (A) or in low (0.5%)
serum containing medium for 36 h followed by 20% serum stimula-
tion for 8 h (B). Cells were harvested and luciferase re£ecting fos
promoter activity and L-galactosidase activities were measured. Re-
sults are expressed as the ratio of luciferase/L-galactosidase for each
sample, thus corresponding to a level in arbitrary units, 1 unit being
the ratio observed with cells transfected with vector alone. Each
transfection was done in triplicate, and each graph is the mean of
three separate experiments.
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